Browsing by Author DeMicco, David A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2014Effect of Change in Body Weight on Incident Diabetes Mellitus in Patients With Stable Coronary Artery Disease Treated With Atorvastatin (from the Treating to New Targets Study)Barter, Philip; Ong, Kwok; Rye, Kerry-Anne; DeMicco, David A; Messig, Michael; Waters, David D; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research Institute; Other or UnknownEffect of Change in Body Weight on Incident Diabetes Mellitus in Patients With Stable Coronary Artery Disease Treated With Atorvastatin (from the Treating to New Targets Study), The American Journal of Cardiology, vol.113, 10, 2014,pp 1593-1598
2013Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-AnalysisKirby, Adrienne; Sullivan, David; Amarenco, Pierre; Arsenault, Benoit J.; Boekholdt, S Matthijs; Colhoun, Helen; DeMicco, David A; et al, Various; Hovingh, G Kees; LaRosa, John C.; Mora, Samia; Pedersen, Terje R; Tonkin, Andrew; Welch, K; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreLevels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis, Circulation, vol.128, 14, 2013,pp 1504-1512
2012Lipid-Modifying Therapies and Risk of Pancreatitis: A Meta-analysisKeech, Anthony (Tony); Colhoun, Helen; DeMicco, David A; Elam, Marshall; et al, Various; Ford, I; Goldenberg, Ilan; laRosa, John C; Lovato, Laura; Preiss, David; Tikkanen, Matti; Welsh, Paul; School of Public Health: NH&MRC Clinical Trials CentreLipid-Modifying Therapies and Risk of Pancreatitis: A Meta-analysis, JAMA: The Journal of the American Medical Association, vol.308, 8, 2012,pp 804-811
2008Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin TreatmentBarter, Philip; Boekholdt, S Matthijs; Cater, Nilo B; Deedwania, Prakash; DeMicco, David A; Gaffney, Michael; Grundy, Scott M; Holme, Ingar; Kastelein, John J.P.; LaRosa, John C.; Olsson, Anders G; Pedersen, Terje R; Szarek, Michael; van der Steeg, Wim A; Central Clinical School: Heart Research InstituteLipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment, Circulation, vol.117, 23, 2008,pp 3002-3009
2012Plasma PCSK9 Levels and Clinical Outcomes in the TNT (Treating to New Targets) Trial: A Nested Case-Control StudyBarter, Philip; Rye, Kerry-Anne; Tabet, Fatiha; Arsenault, Benoit; Bao, Weihang; Boekholdt, S Matthijs; Davaine, Jean-Michel; DeMicco, David A; Huijgen, Roeland; Kastelein, John J. P; Lambert, Gilles; Petrides, Francine; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research InstitutePlasma PCSK9 Levels and Clinical Outcomes in the TNT (Treating to New Targets) Trial: A Nested Case-Control Study, Journal of the American College of Cardiology, vol.59, 20, 2012,pp 1778-1784
2012Relationship between atorvastatin dose and the harm caused by torcetrapibRye, Kerry-Anne; Barter, Philip J.; Beltangady, Mohan S; Boekholdt, S Matthijs; DeMicco, David A; Duggan, William T.; Kastelein, John J.P.; Ports, William C; Shear, Charles; Central Clinical School: Heart Research InstituteRelationship between atorvastatin dose and the harm caused by torcetrapib, Journal of Lipid Research, vol.53, 11, 2012,pp 2436-2442
2014Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trialsKeech, Anthony (Tony); Simes, Robert John; Amarenco, Pierre; Arsenault, Benoit J.; Boekholdt, S Matthijs; Colquhoun, David; DeMicco, David A; et al, Various; Hovingh, G Kees; LaRosa, John C.; Mora, Samia; Pedersen, Terje R; Waters, David; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreVery low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials, Journal of the American College of Cardiology, vol.64, 5, 2014,pp 485-494